GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from prevention and screening, to diagnosis, treatment, therapy, and monitoring. We are an $18 billion business with 51,000 employees working to create a world where healthcare has no limits.

Samsung is committed to create a new future for medical professionals and patients with a mission to bring health and well-being to people’s lives. With this in mind, Samsung Medison, an ultrasound company based in South Korea, is part of this commitment by providing innovative products and solutions for these medical professionals and patients, as well as by supporting life-long healthcare for women by pursuing innovative healthcare solutions in Ob/Gyn ultrasound.

With integration of Samsung’s state-of-the-art technologies in the field of IT, image signal processing, semiconductors and communications, Samsung Medison develops ultrasound AI diagnostic technologies in radiology, OB/GYN, orthopedics and etc, as well as ultrasound machines for fast and accurate diagnosis. In addition, Samsung Medison focuses on guaranteeing efficient workflows and differentiated diagnostic solutions for user conveniences by collaborating with various global enterprises.

Clinical research activities are also performed with worldwide prestigious KOLs to enhance and improve "Access" for easy and quick approach to patients and "Accuracy" for accurate diagnostics not only during examinations, but also in emergency cases and etc. "Efficiency" is also another keyword to improve the conveniences of hospitals and medical professionals. These 3 key words - "Access", "Accuracy" and "Efficiency" are the areas Samsung will continue to focus on and innovate to provide new experiences that goes beyond what medical professionals and patients have experienced before.

Samsung Medison is the innovator in the ultrasound field to support healthcare professionals, will always be there to build a healthier future with continuous researches and innovations.

Burjeel Medical City, the flagship hospital of Burjeel Holdings, is a cutting-edge, leading quaternary care facility in Abu Dhabi, UAE. Boasting a vast expanse of 1.2 million square feet, it accommodates over 350 beds and hosts an array of 60+ specialized medical disciplines. From Oncology, Hematology, and Bone Marrow Transplantation (for both adults and pediatric patients) to Neurosurgery, Multi-Organ Transplantation, Orthopedic Surgery, Pediatric Surgery, Fetal Medicine, Nuclear Medicine, and Advanced Gynecology, among others, the hospital is a hub of advanced medical expertise. From the Kypros Nicolaides Fetal Medicine and Therapy Center to the Paley Middle East Clinic and IFEM Endo Clinic, Burjeel Holdings is home to multiple international centers that offer complex care services.

At Burjeel Medical City, cutting-edge medical technologies are seamlessly integrated into its infrastructure, complemented by a team of Western-board-certified physicians. The hospital’s commitment to innovation is evident in its state-of-the-art rehabilitation facility, featuring advanced equipment like the WalkBot and Exoskeleton Gait Training Robot, alongside the UAE’s largest Hydrotherapy Pool. Among its advanced diagnostic equipment are the 1.5T intraoperative iMRI, advanced MRI systems, CT scanners, PET-CT, SPECT-CT, and HOLOGIC's 3Dimensions™ Mammography System. In radiation oncology, the hospital boasts the most modern facilities, featuring an Elekta Versa HD™ Linear Accelerator and holding the prestigious title of Reference Site for Elekta and Novalis Certified Radiosurgery Centers

Burjeel Medical City’s diagnostic capabilities are unparalleled, with the Co-lab serving as a centralized laboratory equipped with Total Lab Automation and Infinity Lab Solutions, capable of conducting over 10 million tests annually. It houses OncoHelix-CoLab, a first-of-its-kind facility in the UAE with comprehensive capabilities in molecular, cellular immunology, and transplant diagnostics.

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at janssen.com/EMEA or at janssen.com/johnson-johnson-innovative-medicine.

Follow us at J&J Innovative Medicine Europe, Middle East & Africa (EMEA).

At Revvity, “impossible” is inspiration, and "can’t be done" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialization in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharma and biotech, diagnostic labs, academia and governments. Revvity is part of the S&P 500 index and has customers in more than 190 countries.

Revvity products were chosen as the principal screening tool for the ASPRE study. Throughout the study, the Revvity’s DELFIA® Xpress PlGF 1-2-3TM assay was used as an aid in screening for pre-eclampsia in conjunction with maternal history, mean arterial blood pressure (MAP) measurement, and uAD (Uterine Artery Doppler). In 2022, Revvity’s DELFIA® Xpress PlGF 1-2-3TM and DELFIA® Xpress sFlt-1/PlGF Ratio were approved for inclusion in NICE DG-49 diagnostic guidance “PlGF based testing to help diagnose suspected preterm preeclampsia.”

To help facilitate wider access to non-invasive prenatal testing for pregnant women, Revvity offers an easy to use, cost-effective, high-throughput screening system. The Vanadis® cfDNA system is an automated non-sequencing, non-PCR based solution for cfDNA analysis.

At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy DNA and RNA sequence data in studies around the globe. Our microarrays also provide accurate, high-throughput genotyping for a range of applications. Through innovation and collaboration with health care providers and clinical laboratories, we are enabling genomic breakthroughs and using whole-genome sequencing to shorten the patient diagnostic odyssey. At Illumina, we support global efforts for projects that create equitable genome representation, so all populations can benefit from the full health potential of genomic research. We’re empowering our partners to predict and prevent disease, make personalized medicine a reality, and help people understand more about themselves. And this is only the beginning.

B·R·A·H·M·S GmbH, part of Thermo Fisher Scientific, investigates, develops and manufactures novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With high-quality immunodiagnostic tests for prenatal screening, cardiovascular, pulmonary, and cancer disorders as well as for sepsis, the company contributes to the creation of a healthier future – to the greatest advantage for medical professionals and patients.

In future simple and economic blood tests will be of great importance for an early detection and successful treatment of diseases. With our know-how and technologies we are confident to play an active role in this future: Our products provide important information to clinicians and laboratories in more than 130 countries worldwide, supporting their clinically and economically relevant decisions.

The B·R·A·H·M·S KRYPTOR platforms and the B·R·A·H·M·S biomarkers for prenatal screening are CE certified and approved by the Fetal Medicine Foundation (FMF), the portfolio comes up to the quality standards of the FMF since 1999.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche Sequencing Solution of Roche is focused on developing novel technologies and products to support innovation in clinical research applications. Part of Roche Sequencing Solutions, the Harmony^® prenatal test is a non-invasive screening test for pregnant women that can be used as early as 10 weeks of pregnancy. By evaluating fetal cell-free DNA found in maternal blood, including accurate measurement of the fetal fraction of cfDNA, the test assesses the probability of Trisomy 21 (Down syndrome) and other common fetal chromosomal conditions. The results are intended for prenatal screening and are not intended to be the sole basis for diagnosis. The Harmony^® prenatal test has been used to guide clinical care in over 1,400,000 pregnancies worldwide.

Sonio is an AI-software guiding practitioners during prenatal ultrasound scans to secure prenatal screening and optimize prenatal diagnosis.

Designed for prenatal diagnosis experts, Sonio Diagnostics combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis.

Suitable for all routine exams, Sonio Screening, assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitating the sharing of images with patients and other health professionals.

Philips is one of the world’s leading technology companies, with a long history of practical innovation and visionary design. In healthcare, we are committed to understanding the human and technological needs of patients and caregivers. We believe this understanding will help us deliver solutions that not only enable more confident diagnoses and more efficient delivery of care, but also improve the overall experience of care. We offer equipment, software, and services for imaging, patient monitoring, resuscitation and much more. Visit us at booth to learn more. People focused. Healthcare simplified.

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

Labcorp is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. Learn more about us at www.labcorp.com.

VOLUTRACER OPUS ® is a high-fidelity ultrasound optical positioning simulator. It is the perfect solution for the education and training of students, residents and experts of all levels. Uses real high resolution 2D cases. It has an online Cloud, to download courses, normal and pathological, in a wide range of anatomical regions. It is an open platform that allows the user to create their own content using their own case library. Thanks to its optical positioning scanning system, it allows 6 degrees of freedom of the hand making the practice a realistic experience. Simple and lightweight, VOLUTRACER OPUS ® is perfect for practicing everywhere, whether at home, classroom, workshops and more. Everything that can be scanned can be trained in VOLUTRACER OPUS ®.

astraia software gmbh provides software solutions in obstetrics and gynaecology for structured documentation and reporting, as well as for scientific studies. The company was founded in 2000 and is based in Ismaning (Munich), Germany. A dedicated team of about 30 employees serves more than 1,700 customers in over 75 countries. In many countries, astraia is also represented by local sales partners.

We are supported by leading experts from all over the world to guarantee a comprehensive, practical and efficient documentation of the examinations with advanced medical functionalities, based on the latest knowledge and standardized terminology in around 20 languages.

Canon Medical offers a full range of diagnostic medical imaging solutions including CT, MR, X-Ray, Ultrasound and Healthcare Informatics across the globe.
In line with our Made for Life philosophy, patients are at the heart of everything we do.
Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide.
Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features.

At Canon Medical we work hand in hand with our partners – our medical, academic and research community.
We build relationships based on transparency, trust and respect.
Together as one, we strive to create industry-leading solutions that deliver an enriched quality of life